Hi Georgia: This molecular similarity between the spike protein and hepcidin may play a role in SARS-CoV-2 infection, but it does not seem to apply to the mRNA vaccines in any way (probably not the other vaccines either).
This is from the abstract of the study you quoted:
"The spike glycoprotein of the SARS-CoV-2 virus, which causes COVID-19, has attracted attention for its vaccine potential and binding capacity to host cell surface receptors. Much of this research focus has centered on the ectodomain of the spike protein. The ectodomain is anchored to a transmembrane region, followed by a cytoplasmic tail. Here we report a distant sequence similarity between the cysteine-rich cytoplasmic tail of the coronavirus spike protein and the hepcidin protein that is found in humans and other vertebrates."
https://biologydirect.biomedcentral.com/articles/10.1186/s13062-020-00275-2So sequence similarity in "cytoplasmic tail", but mRNA vaccines use "ectodomain version" of spike protein...
"The two mRNA vaccines that have received emergency use authorizations — BNT162b2 (Pfizer/BioNTech) and mRNA-1273 (Moderna) — encode a stabilized ectodomain version of the spike (S) protein from the Wuhan-Hu-1 variant of SARS-CoV-2 (isolated in 2019)."
https://www.nature.com/articles/s41577-021-00548-5I can't say for sure what's going on in those magnet videos.. not taking them at face value myself.